Pien Tze Huang Inhibits the Growth of Hepatocellular Carcinoma Cells by Upregulating MiR-16 Expression

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Jan 19

PMID 29344256

Citations 10

Authors

Fei Qi

Songqiang Zhou

Li Li

Lihui Wei

Aling Shen

Liya Liu

Yaodong Wang

Jun Peng

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is characterized by uncontrolled proliferation and the deregulation of apoptotic signaling, although its molecular pathogenesis is not fully characterized. The ability to inhibit excessive proliferation and induce the apoptosis of cancer cells are crucial characteristics of anticancer drugs. Pien Tze Huang (PZH) is a widely used traditional Chinese medicine for the treatment of various types of cancer, and has exhibited promising therapeutic effects in clinical trials of HCC. However, the underlying mechanisms for its action are unclear. In the present study, the aim was to explore the effect of PZH on the proliferation and apoptosis of the BEL-7402 HCC cell line, and the associated mechanisms. PZH treatment significantly inhibited BEL-7402 cell viability, confluence and clonogenicity, inducing cell cycle arrest and promoting apoptosis. In addition, PZH treatment suppressed the expression of the pro-proliferative genes cyclin D1 and cyclin-dependent kinase 4, and decreased the expression of the anti-apoptotic gene Bcl-2. PZH treatment also upregulated the expression of a key microRNA (miR), miR-16. The study demonstrated that PZH can effectively inhibit cancer cell proliferation and induce apoptosis in BEL-7402 HCC cells via the upregulation of the tumor suppressor miR-16.

Citing Articles

Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.

Cao L, Liu L, Chen Y, Han Y, Wei L, Yao M Chin J Integr Med. 2024; 30(6):515-524.

PMID: 38216838 DOI: 10.1007/s11655-024-3709-5.

Pien-Tze-Huang alleviates CCl-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway.

Zhang Y, Hua L, Lin C, Yuan M, Xu W, Raj D A Front Pharmacol. 2022; 13:937484.

PMID: 36188553 PMC: 9523731. DOI: 10.3389/fphar.2022.937484.

Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity.

Luo Z, Tian Q, Cheng N, Liu W, Yang Y, Chen W Chin J Integr Med. 2022; 30(2):115-124.

PMID: 35947230 DOI: 10.1007/s11655-022-3533-8.

Drug response biomarkers of Pien Tze Huang treatment for hepatic fibrosis induced by carbon tetrachloride.

Di Z, Muyun W, Luan C, Hao W, Ting W, Zhiruo Z J Tradit Chin Med. 2022; 42(4):530-538.

PMID: 35848969 PMC: 9924746. DOI: 10.19852/j.cnki.jtcm.2022.04.003.

Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p.

Zhang Y, Lu C, Cui H Bioengineered. 2021; 12(1):7446-7458.

PMID: 34652260 PMC: 8806779. DOI: 10.1080/21655979.2021.1975969.

References

Peng J, Tan C, Roberts G, Nikolaeva O, Zhang Z, Lapolla S . tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation. J Biol Chem. 2006; 281(47):35802-11. PMC: 2825177. DOI: 10.1074/jbc.M608303200. View

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

Forner A, Llovet J, Bruix J . Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-55. DOI: 10.1016/S0140-6736(11)61347-0. View

Uhlmann S, Zhang J, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S . miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010; 29(30):4297-306. DOI: 10.1038/onc.2010.201. View

Leskela S, Leandro-Garcia L, Mendiola M, Barriuso J, Inglada-Perez L, Munoz I . The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 2010; 18(1):85-95. DOI: 10.1677/ERC-10-0148. View

Wei L, Chen P, Chen Y, Shen A, Chen H, Lin W . Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells. Mol Med Rep. 2013; 9(1):261-6. DOI: 10.3892/mmr.2013.1760. View

Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q . Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Int J Oncol. 2014; 46(2):685-90. DOI: 10.3892/ijo.2014.2772. View

Qi F, Wei L, Shen A, Chen Y, Lin J, Chu J . Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway. Oncol Rep. 2015; 35(1):511-7. DOI: 10.3892/or.2015.4378. View

Huang Y, Lin K, Chen H, Chang M, Hsu C, Lai M . Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One. 2012; 7(5):e37188. PMC: 3358336. DOI: 10.1371/journal.pone.0037188. View

10.

Shen A, Chen Y, Hong F, Lin J, Wei L, Hong Z . Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3. Oncol Rep. 2012; 28(6):2125-30. DOI: 10.3892/or.2012.2067. View

11.

Bar N, Dikstein R . miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One. 2010; 5(5):e10859. PMC: 2877705. DOI: 10.1371/journal.pone.0010859. View

12.

Shen A, Lin J, Chen Y, Lin W, Liu L, Hong Z . Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways. Oncol Rep. 2013; 30(4):1701-6. DOI: 10.3892/or.2013.2609. View

13.

Li H, Tang J, Lei H, Cai P, Zhu H, Li B . Decreased MiR-200a/141 suppress cell migration and proliferation by targeting PTEN in Hirschsprung's disease. Cell Physiol Biochem. 2014; 34(2):543-53. DOI: 10.1159/000363021. View

14.

Peng J, Ding J, Tan C, Baggenstoss B, Zhang Z, Lapolla S . Oligomerization of membrane-bound Bcl-2 is involved in its pore formation induced by tBid. Apoptosis. 2009; 14(10):1145-53. PMC: 2858642. DOI: 10.1007/s10495-009-0389-8. View

15.

Tsang W, Kwok T . Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem. 2009; 21(2):140-6. DOI: 10.1016/j.jnutbio.2008.12.003. View

16.

Bagga S, Pasquinelli A . Identification and analysis of microRNAs. Genet Eng (N Y). 2005; 27:1-20. DOI: 10.1007/0-387-25856-6_1. View

17.

Cai C, Zhao G, Tian L, Liu L, Yan K, Ma Y . miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep. 2012; 28(5):1764-70. DOI: 10.3892/or.2012.1995. View

18.

Shen A, Hong F, Liu L, Lin J, Wei L, Cai Q . Pien Tze Huang inhibits the proliferation of human colon carcinoma cells by arresting G1/S cell cycle progression. Oncol Lett. 2012; 4(4):767-770. PMC: 3506678. DOI: 10.3892/ol.2012.811. View

19.

Pekarsky Y, Croce C . Role of miR-15/16 in CLL. Cell Death Differ. 2014; 22(1):6-11. PMC: 4262785. DOI: 10.1038/cdd.2014.87. View

20.

Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E . Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002; 99(24):15524-9. PMC: 137750. DOI: 10.1073/pnas.242606799. View